There are many well-established correlations between warfarin dosing and therapeutic endpoints. One realm we’re still working to conquer includes the influence of genetics on the application of warfarin and other medicines. Ann Wittkowsky, PharmD, director of anticoagulation services at the University of Washington Medical Center in Seattle, joins host Dr. Charles Turck to examine the potential impact of genetics in pharmacotherapeutics.
Genetics in Anticoagulant Pharmacotherapy
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Overview
There are many well-established correlations between warfarin dosing and therapeutic endpoints. One realm we’re still working to conquer includes the influence of genetics on the application of warfarin and other medicines. Ann Wittkowsky, PharmD, director of anticoagulation services at the University of Washington Medical Center in Seattle, joins host Dr. Charles Turck to examine the potential impact of genetics in pharmacotherapeutics.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
How COVID-19 Is Affecting Life Outside of the Office: A Dermatologist’s Experience
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
Clinical Considerations for the Diagnosis of Endometriosis
Biomarkers of the Storm: Decoding IRI’s Signature
Application of guidelines-recommended broad molecular profiling to patients with NSCLC
Guideline Considerations for Immunotherapy in Primary Advanced or Recurrent Endometrial Cancer
Immunotherapy for TNBC in the Perioperative Setting: Clinical Evidence and Considerations
Navigating Myasthenia Gravis in Adolescents and Young Adults
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?